首页> 美国卫生研究院文献>World Journal of Gastroenterology >Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue and its possible role in tumor immunity
【2h】

Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue and its possible role in tumor immunity

机译:共刺激物4-1BB分子在肝细胞癌及附近非肿瘤肝组织中的表达及其在肿瘤免疫中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the expression of 4-1BB molecule in hepatocellular carcinoma (HCC) and its adjacent tissues.METHODS: Reverse transcription–polymerase chain reaction (RT-PCR) was used to determine the gene expression of 4-1BB in hepatocarcinoma and its adjacent tissues, and peripheral blood mononuclear cells (PBMCs) from both HCC and health control groups. Flow cytometry was used to analyse the phenotypes of T cell subsets from the blood of HCC patients and healthy volunteers, and further to determine whether 4-1BB molecules were also expressed on the surface of CD4+ and CD8+ T cells. The localization of 4-1BB proteins on tumor infiltrating T cells was determined by direct immunofluorescence cytochemical staining and detected by confocal microscopy.RESULTS: 4-1BB mRNA, which was not detectable in normal liver, was found in 19 liver tissues adjacent to tumor edge (< 1.0 cm). Low expression of 4-1BB mRNA was shown in 8 tumor tissues and 6 liver tissues located within 1 to 5 cm away from tumor edge. In PBMCs, 4-1BB mRNA was almost not detected. Percentage of CD4+, CD8+ and CD3+/CD25+ T cells, as well as ratio of CD4 to CD8 revealed no difference between groups (P > 0.05, respectively), while a significant lower percentage of CD3+ T cell was found in HCC group as compared to healthy control group (P < 0.05). However, 4-1BB molecules were almost not found on the surface of CD4+ and CD8+ T cells in HCC and healthy control group. Double-staining of 4-1BB+/CD4+ and 4-1BB+/CD8+ immunofluorescence on tumor infiltrating T cells was detected in 13 liver tissues adjacent to tumor edge (< 1.0 cm) by confocal microscopy.CONCLUSION: Although HCC may escape from immune attack by weak immunogenicity or downregulated expression of MHC-1 molecules on the tumor cell surface, tumor infiltrating T cells can be activated via other costimulatory signal pathways to exert a limited antitumor effect on local microenvironment. The present study also implicates that modulating 4-1BB/4-1BBL costimulatory pathway may be an effective immunotherapy strateg to augment the host response.
机译:目的:探讨4-1BB分子在肝癌及其癌旁组织中的表达。方法:采用逆转录聚合酶链反应(RT-PCR)法检测4-1BB在肝癌及其癌旁组织中的表达。肝癌和健康对照组的患者周围组织和外周血单核细胞(PBMC)。流式细胞仪用于分析HCC患者和健康志愿者血液中T细胞亚型的表型,并进一步确定4-1BB分子是否也在CD4 +和CD8 + T细胞表面表达。通过直接免疫荧光细胞化学染色确定4-1BB蛋白在肿瘤浸润T细胞中的定位并通过共聚焦显微镜检测。结果:在正常肝中未检测到的4-1BB mRNA在邻近肿瘤边缘的19个肝组织中被发现(<1.0厘米)。在距肿瘤边缘1至5 cm的8个肿瘤组织和6个肝组织中显示4-1BB mRNA的低表达。在PBMC中,几乎未检测到4-1BB mRNA。 CD4 + ,CD8 + 和CD3 + / CD25 + T细胞的百分比以及CD4的比例CD8对CD8的检测显示两组间无差异(分别为P> 0.05),而HCC组的CD3 + T细胞百分比显着低于健康对照组(P <0.05)。然而,在肝癌和健康对照组的CD4 +和CD8 + T细胞表面几乎没有发现4-1BB分子。 4-1BB + / CD4 + 和4-1BB + / CD8 + 对肿瘤的双重染色共聚焦显微镜在肿瘤边缘附近(<1.0 cm)的13个肝组织中检测到浸润性T细胞。结论:尽管HCC可能由于免疫原性弱或肿瘤细胞表面MHC-1分子表达下调而逃脱了免疫攻击,但肿瘤浸润T细胞可以通过其他共刺激信号途径激活,从而对局部微环境产生有限的抗肿瘤作用。本研究还暗示调节4-1BB / 4-1BBL共刺激途径可能是增强宿主反应的有效免疫治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号